AlphaCentric Advisors »

Chemed Corp Com Stk shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Chemed Corp Com Stk (CHE) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Chemed Corp Com Stk

Tip: Access up to 7 years of quarterly data

All positions including Chemed Corp Com Stk held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemed Corp Com Stk by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $520k 982 529.80

More positions owned by AlphaCentric Advisors

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Abbvie (ABBV)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Astrazeneca Sponsored Adr (AZN)
Novo-nordisk A S Adr (NVO)
Globus Med Cl A (GMED)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Intuitive Surgical Com New (ISRG)
Lamar Advertising Cl A (LAMR)
Boston Scientific Corporation (BSX)

View all positions for AlphaCentric Advisors

Top funds holding Chemed Corp Com Stk

Vanguard Group
BlackRock
Kayne Anderson Rudnick Investment Management
Jpmorgan Chase & Co
State Street Corporation
Neuberger Berman Group
William Blair Investment Management
Geode Capital Management
Morgan Stanley
Epoch Investment Partners
TD Asset Management
Impax Asset Management Group
Acadian Asset Management
Dimensional Fund Advisors
Btim

View all funds holding Chemed Corp Com Stk